Joon Lee
Stock Analyst at Truist Securities
(4.78)
# 116
Out of 5,055 analysts
113
Total ratings
62.16%
Success rate
41.43%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joon Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALKS Alkermes | Reiterates: Buy | $50 | $29.04 | +72.18% | 2 | Nov 12, 2025 | |
| NTLA Intellia Therapeutics | Reiterates: Buy | $25 → $14 | $8.70 | +60.92% | 5 | Nov 10, 2025 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $100 → $90 | $33.08 | +172.07% | 1 | Nov 5, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $90 → $80 | $54.73 | +46.17% | 3 | Oct 28, 2025 | |
| PRAX Praxis Precision Medicines | Reiterates: Buy | $85 → $360 | $186.42 | +93.11% | 6 | Oct 17, 2025 | |
| RAPP Rapport Therapeutics | Initiates: Buy | $44 | $24.34 | +80.81% | 1 | Sep 16, 2025 | |
| ARGX argenx SE | Maintains: Buy | $700 → $918 | $907.98 | +1.10% | 13 | Sep 15, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $520 → $490 | $437.15 | +12.09% | 4 | Aug 5, 2025 | |
| PTCT PTC Therapeutics | Maintains: Buy | $80 → $86 | $75.30 | +14.21% | 2 | Jul 29, 2025 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $95 → $75 | $39.11 | +91.77% | 8 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $21 | $10.57 | +98.68% | 6 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $76 → $150 | $75.51 | +98.65% | 8 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $200 | $139.69 | +43.17% | 5 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $120 | $52.53 | +128.44% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $3.38 | +432.54% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $4.24 | +277.36% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $36 | $7.08 | +408.47% | 3 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $23.18 | +55.31% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $2.60 | +207.69% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $17 | $11.24 | +51.25% | 7 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $40 | $4.29 | +832.40% | 6 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $141.07 | +41.77% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $4.13 | +21.07% | 7 | Sep 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $3.94 | +357.43% | 1 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $280 | $1.36 | +20,488.24% | 1 | Oct 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $27 → $34 | $33.82 | +0.53% | 1 | Mar 16, 2021 |
Alkermes
Nov 12, 2025
Reiterates: Buy
Price Target: $50
Current: $29.04
Upside: +72.18%
Intellia Therapeutics
Nov 10, 2025
Reiterates: Buy
Price Target: $25 → $14
Current: $8.70
Upside: +60.92%
Ultragenyx Pharmaceutical
Nov 5, 2025
Maintains: Buy
Price Target: $100 → $90
Current: $33.08
Upside: +172.07%
BioMarin Pharmaceutical
Oct 28, 2025
Maintains: Buy
Price Target: $90 → $80
Current: $54.73
Upside: +46.17%
Praxis Precision Medicines
Oct 17, 2025
Reiterates: Buy
Price Target: $85 → $360
Current: $186.42
Upside: +93.11%
Rapport Therapeutics
Sep 16, 2025
Initiates: Buy
Price Target: $44
Current: $24.34
Upside: +80.81%
argenx SE
Sep 15, 2025
Maintains: Buy
Price Target: $700 → $918
Current: $907.98
Upside: +1.10%
Vertex Pharmaceuticals
Aug 5, 2025
Maintains: Buy
Price Target: $520 → $490
Current: $437.15
Upside: +12.09%
PTC Therapeutics
Jul 29, 2025
Maintains: Buy
Price Target: $80 → $86
Current: $75.30
Upside: +14.21%
Viking Therapeutics
Apr 28, 2025
Reiterates: Buy
Price Target: $95 → $75
Current: $39.11
Upside: +91.77%
Apr 9, 2025
Maintains: Buy
Price Target: $65 → $21
Current: $10.57
Upside: +98.68%
Mar 31, 2025
Maintains: Buy
Price Target: $76 → $150
Current: $75.51
Upside: +98.65%
Feb 19, 2025
Maintains: Buy
Price Target: $190 → $200
Current: $139.69
Upside: +43.17%
Feb 12, 2025
Maintains: Buy
Price Target: $100 → $120
Current: $52.53
Upside: +128.44%
Jan 29, 2025
Initiates: Buy
Price Target: $18
Current: $3.38
Upside: +432.54%
Jan 8, 2025
Initiates: Buy
Price Target: $16
Current: $4.24
Upside: +277.36%
Nov 12, 2024
Maintains: Buy
Price Target: $17 → $36
Current: $7.08
Upside: +408.47%
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $23.18
Upside: +55.31%
Nov 5, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $2.60
Upside: +207.69%
Oct 22, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $11.24
Upside: +51.25%
Aug 14, 2024
Maintains: Buy
Price Target: $60 → $40
Current: $4.29
Upside: +832.40%
Mar 20, 2024
Reiterates: Buy
Price Target: $200
Current: $141.07
Upside: +41.77%
Sep 20, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $4.13
Upside: +21.07%
May 10, 2023
Initiates: Buy
Price Target: $18
Current: $3.94
Upside: +357.43%
Oct 20, 2021
Initiates: Buy
Price Target: $280
Current: $1.36
Upside: +20,488.24%
Mar 16, 2021
Upgrades: Buy
Price Target: $27 → $34
Current: $33.82
Upside: +0.53%